Table 1 Baseline characteristics of 4 groups
Variable | Q1 (n = 81) | Q2 (n = 80) | Q3 (n = 79) | Q4 (n = 80) | P value |
|---|---|---|---|---|---|
TyG index | 8.00 ± 0.27 | 8.63 ± 0.14 | 9.14 ± 0.16 | 10.00 ± 0.55 |  < 0.001 |
Age, years | 69.3 ± 8.9 | 65.3 ± 10.9 | 67.3 ± 9.5 | 65.15 ± 11.7 | 0.036 |
Male | 33 (40.7) | 44 (55.0) | 40 (50.6) | 45 (56.3) | 0.188 |
BMI, kg/m2 | 22.7 ± 3.2 | 23.3 ± 2.9 | 24.6 ± 3.3 | 25.0 ± 2.7 |  < 0.001 |
SBP, mmHg | 136.8 ± 25.5 | 140.9 ± 22.4 | 140.4 ± 21.8 | 141.2 ± 23.4 | 0.612 |
DBP, mmHg | 80.5 ± 14.9 | 83.2 ± 14.6 | 82.0 ± 10.6 | 81.6 ± 11.6 | 0.613 |
Heart rate, bpm | 73.3 ± 14.5 | 76.1 ± 14.3 | 78.1 ± 13.2 | 78.8 ± 13.8 | 0.064 |
Smoker | 2 (2.5) | 9 (11.3) | 24 (30.4) | 53 (66.3) |  < 0.001 |
Drinker | 0 (0) | 2 (2.5) | 3 (3.8) | 23 (28.7) |  < 0.001 |
H-type hypertension | 40 (49.4) | 28 (35.0) | 40(50.6) | 46 (57.5) | 0.035 |
METS-IR index | 32.0 ± 5.7 | 35.2 ± 5.3 | 39.2 ± 6.2 | 45.3 ± 7.3 |  < 0.001 |
Diabetes mellitus | 13 (16.0) | 21 (26.3) | 25 (31.6) | 36 (45.0) | 0.001 |
Metabolic syndrome | 0(0) | 0(0) | 3(3.8) | 43 (53.8) |  < 0.001 |
Biochemical indicators | |||||
 WBC, 109/L | 5.7 ± 1.9 | 6.3 ± 2.1 | 6.4 ± 2.1 | 7.1 ± 1.9 | 0.001 |
 Neutrophil ratio | 65.9 ± 9.8 | 65.9 ± 10.6 | 65.6 ± 11.0 | 67.7 ± 9.2 | 0.533 |
 Platelet, 109/L | 199.5 ± 50.7 | 211.1 ± 61.1 | 227.1 ± 74.0 | 225.5 ± 54.4 | 0.013 |
 Albumin, g/L | 40.9 ± 4.0 | 41.8 ± 4.2 | 42.2 ± 3.5 | 41.8 ± 3.4 | 0.171 |
 Homocysteine | 18.1 ± 9.2 | 16.2 ± 6.7 | 17.5 ± 7.1 | 18.2 ± 7.1 | 0.129 |
 FPG, mg/dL | 103.5 ± 19.2 | 117.4 ± 31.1 | 137.0 ± 37.6 | 200.0 ± 97.3 |  < 0.001 |
 TC, mg/dL | 147.1 ± 40.9 | 155.5 ± 44.2 | 167.4 ± 47.2 | 175.7 ± 49.2 |  < 0.001 |
 TG, mg/dL | 62.3 ± 18.2 | 101.6 ± 22.4 | 147.4 ± 41.6 | 293.0 ± 265.9 |  < 0.001 |
 HDL-C, mg/dL | 57.4 ± 17.3 | 49.6 ± 11.8 | 46.1 ± 10.9 | 37.8 ± 9.3 |  < 0.001 |
 LDL-C, mg/dL | 72.4 ± 29.1 | 85.7 ± 37.2 | 95.9 ± 39.5 | 98.6 ± 36.3 |  < 0.001 |
 Uric acid, mg/dL | 6.1 ± 1.9 | 6.1 ± 1.8 | 6.7 ± 1.8 | 6.9 ± 2.0 | 0.011 |
 SCr, mg/dL | 79.4 ± 42.1 | 85.8 ± 60.3 | 81.0 ± 32.7 | 81.9 ± 27.2 | 0.804 |
Coronary angiography | |||||
 Lesion vessels | 0.7 ± 1.0 | 1.2 ± 1.2 | 1.4 ± 1.1 | 2.1 ± 1.0 |  < 0.001 |
 Three-vessel disease | 20 (24.7) | 30 (37.5) | 39 (49.4) | 61 (76.3) |  < 0.001 |
 Gensini score, (IQR) | 30.5 (20.5,43.5) | 32.0 (20.0,44.0) | 42.5 (29.0,61.0) | 66.5 (51.0,97.1) |  < 0.001 |
Medications use at discharge | |||||
 Antiplatelet | 14 (17.3) | 16 (20.0) | 16 (20.3) | 20 (25.0) | 0.679 |
 Statin | 8 (9.9) | 6 (7.5) | 9 (11.4) | 8 (10.0) | 0.870 |
 CCB | 22 (27.2) | 11 (13.8) | 10 (12.7) | 16 (20.0) | 0.067 |
 Beta blockers | 11 (13.6) | 4 (5.0) | 9 (11.4) | 7 (8.8) | 0.289 |
 ACEI/ARB | 15 (18.5) | 5 (6.3) | 3 (3.8) | 0 (0) |  < 0.001 |